• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对美国国立癌症研究所体外抗肿瘤筛选数据库的多变量洞察:化合物分类、细胞系间的相似性以及分子靶点的影响。

A multivariate insight into the in vitro antitumour screen database of the National Cancer Institute: classification of compounds, similarities among cell lines and the influence of molecular targets.

作者信息

Musumarra G, Condorelli D F, Costa A S, Fichera M

机构信息

Dipartimento di Scienze Chimiche, Università di Catania, Italy.

出版信息

J Comput Aided Mol Des. 2001 Mar;15(3):219-34. doi: 10.1023/a:1008171426412.

DOI:10.1023/a:1008171426412
PMID:11289076
Abstract

A multivariate insight into the in vitro antitumour screen database of the NCI by means of the SIMCA package allows to propose hypotheses on the mechanism of action of novel anticancer compounds. As an example, the application of multivariate analysis to the NCI standard database provided clues to the classification of drugs whose mechanism is either unknown or controversial. Moreover, the influence of intrinsic biochemical cell line properties (molecular targets) on the sensitivity to drug treatment could be evaluated simultaneously for classes of compounds which act by the same mechanism. Interestingly, the present approach can also provide a correlation between the molecular targets and the therapeutical fingerprint of novel active compounds thus suggesting specific biochemical studies for the investigation of new mechanisms of drug action and resistance. The statistical approach reported here represents a valuable tool for handling theenormous data sets deriving from recent genome-wide investigations of gene expression in the NCI cell lines.

摘要

借助SIMCA软件包对美国国立癌症研究所(NCI)的体外抗肿瘤筛选数据库进行多变量分析,有助于对新型抗癌化合物的作用机制提出假设。例如,将多变量分析应用于NCI标准数据库,为作用机制不明或有争议的药物分类提供了线索。此外,对于通过相同机制起作用的化合物类别,可以同时评估内在生化细胞系特性(分子靶点)对药物治疗敏感性的影响。有趣的是,目前的方法还可以提供分子靶点与新型活性化合物治疗指纹之间的相关性,从而为研究药物作用和耐药性的新机制提出具体的生化研究方向。本文报道的统计方法是处理来自NCI细胞系近期全基因组基因表达研究产生的大量数据集的宝贵工具。

相似文献

1
A multivariate insight into the in vitro antitumour screen database of the National Cancer Institute: classification of compounds, similarities among cell lines and the influence of molecular targets.对美国国立癌症研究所体外抗肿瘤筛选数据库的多变量洞察:化合物分类、细胞系间的相似性以及分子靶点的影响。
J Comput Aided Mol Des. 2001 Mar;15(3):219-34. doi: 10.1023/a:1008171426412.
2
Shortcuts in genome-scale cancer pharmacology research from multivariate analysis of the National Cancer Institute gene expression database.基于美国国立癌症研究所基因表达数据库多变量分析的基因组规模癌症药理学研究捷径
Biochem Pharmacol. 2001 Sep 1;62(5):547-53. doi: 10.1016/s0006-2952(01)00711-0.
3
Mining and visualizing large anticancer drug discovery databases.挖掘和可视化大型抗癌药物发现数据库。
J Chem Inf Comput Sci. 2000 Mar-Apr;40(2):367-79. doi: 10.1021/ci990087b.
4
Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.将通路基因表达与美国国立癌症研究所抗癌筛选的生长抑制反应及药物作用机制联系起来。
Pharmacogenomics J. 2005;5(6):381-99. doi: 10.1038/sj.tpj.6500331.
5
An information-intensive approach to the molecular pharmacology of cancer.一种针对癌症分子药理学的信息密集型方法。
Science. 1997 Jan 17;275(5298):343-9. doi: 10.1126/science.275.5298.343.
6
Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations.利用美国国立癌症研究所抗癌药物筛选和聚类图像图谱可视化技术鉴定具有新型细胞毒性谱的非交叉耐药铂化合物。
Crit Rev Oncol Hematol. 2005 Jan;53(1):25-34. doi: 10.1016/j.critrevonc.2004.09.008.
7
Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.挖掘美国国立癌症研究所癌细胞系化合物的半数抑制浓度(GI(50))值:识别对黑色素瘤和白血病细胞类型有效的醌亚型。
J Chem Inf Comput Sci. 2003 Sep-Oct;43(5):1652-67. doi: 10.1021/ci034050+.
8
Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of action.应用于美国国立癌症研究所体外抗肿瘤药物筛选的鉴别技术:预测生化作用机制
Stat Med. 1994;13(5-7):719-30. doi: 10.1002/sim.4780130532.
9
Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity.挖掘美国国立癌症研究所抗癌药物发现数据库:对具有p53反向和中枢神经系统选择性活性模式的玫瑰树碱类似物进行聚类分析。
Mol Pharmacol. 1998 Feb;53(2):241-51. doi: 10.1124/mol.53.2.241.
10
Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.人类癌细胞系面板为药物发现和生物信息学提供了有价值的数据库。
Cancer Chemother Pharmacol. 2003 Jul;52 Suppl 1:S74-9. doi: 10.1007/s00280-003-0649-1. Epub 2003 Jun 18.

引用本文的文献

1
N-benzoxazol-2-yl-N'-1-(isoquinolin-3-yl-ethylidene)-hydrazine, a novel compound with antitumor activity, induces radicals and dissipation of mitochondrial membrane potential.N-苯并恶唑-2-基-N'-1-(异喹啉-3-基-亚乙基)-肼,一种具有抗肿瘤活性的新型化合物,可诱导自由基产生并使线粒体膜电位耗散。
Invest New Drugs. 2009 Jun;27(3):189-202. doi: 10.1007/s10637-008-9156-x. Epub 2008 Jul 9.

本文引用的文献

1
Levels of messenger-RNA coding for DNA topoisomerase-ii isoforms do not correlate with in-vitro drug-sensitivity.编码DNA拓扑异构酶II亚型的信使核糖核酸水平与体外药物敏感性无关。
Oncol Rep. 1994 Sep;1(5):907-11. doi: 10.3892/or.1.5.907.
2
A gene expression database for the molecular pharmacology of cancer.一个用于癌症分子药理学的基因表达数据库。
Nat Genet. 2000 Mar;24(3):236-44. doi: 10.1038/73439.
3
Systematic variation in gene expression patterns in human cancer cell lines.人类癌细胞系中基因表达模式的系统性变化。
Nat Genet. 2000 Mar;24(3):227-35. doi: 10.1038/73432.
4
New approaches to understanding p53 gene tumor mutation spectra.理解p53基因肿瘤突变谱的新方法。
Mutat Res. 1999 Dec 17;431(2):199-209. doi: 10.1016/s0027-5107(99)00162-1.
5
Sequence and structural selectivity of nucleic acid binding ligands.核酸结合配体的序列和结构选择性
Biochemistry. 1999 Dec 7;38(49):16067-75. doi: 10.1021/bi992070s.
6
Using the national cancer institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profiles.使用美国国立癌症研究所的抗癌药物筛选来评估多药耐药相关蛋白(MRP)表达对药物敏感性谱的影响。
Mol Pharmacol. 1998 Nov;54(5):802-14. doi: 10.1124/mol.54.5.802.
7
The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs.
Chem Biol Interact. 1998 Apr 24;111-112:255-62. doi: 10.1016/s0009-2797(97)00165-8.
8
Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analogues.挖掘美国国立癌症研究所抗癌药物发现数据库:用于抗癌椭圆玫瑰树碱类似物定量构效关系研究的基因功能近似法。
J Chem Inf Comput Sci. 1998 Mar-Apr;38(2):189-99. doi: 10.1021/ci970085w.
9
Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity.挖掘美国国立癌症研究所抗癌药物发现数据库:对具有p53反向和中枢神经系统选择性活性模式的玫瑰树碱类似物进行聚类分析。
Mol Pharmacol. 1998 Feb;53(2):241-51. doi: 10.1124/mol.53.2.241.
10
Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel.美国国立癌症研究所肿瘤样本库中金属硫蛋白含量及亚细胞定位的多样性
Cancer Chemother Pharmacol. 1997;41(1):61-8. doi: 10.1007/s002800050708.